Senate Votes ‘Yes’ to Califf as Next FDA Commissioner

February 25, 2016

On Tuesday, February 23, the US Senate confirmed Robert Califf, MD to serve as the next FDA Commissioner. The position, held by Margaret Hamburg, MD for six years until she resigned in March 2015, was temporarily held by Stephen Ostroff, MD. Dr. Ostroff served as the Acting Commissioner for the ten month duration during which the final decision was being made regarding the appointment of the next Commissioner.

The Senate did not arrive at this decision without challenges; Califf, nominated by President Obama in September of last year, has received a lot of criticism. Ultimately, the objections were overcome although not unanimously; the final vote was 89-4.

For more information about Dr. Califf’s journey, view our previous FDA News articles:


November 12, 2018

FDA Approves New Opioid Despite Controversy

On Friday, November 2nd, FDA announced its approval of Dsuvia™, a highly potent synthetic opioid manufactured by AcelRx Pharmaceuticals, Inc. The drug is a sublingual (under the tongue) formulation...

March 24, 2016

Opioid Epidemic: FDA “Ups the Ante” on Labeling Requirements for Opioid Painkillers

On Tuesday, March 22 the FDA announced class-wide safety labeling changes for all immediate-release opioid painkillers. FDA stated that these changes are being made as part of the Agency's...

December 16, 2015

FDA’s Center for Drug Evaluation & Research: 2016 Priorities

FDA’s Center for Drug Evaluation & Research (CDER) 2016 Priorities & Areas of Focus Front Burner Priorities: Negotiate PDUFA 6 agreements Negotiate GDUFA 2 agreements Negotiate a second BSUFA program...